Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Immunol. 2010 May;10(5):345-52. doi: 10.1038/nri2747.

Strategies and challenges for the next generation of therapeutic antibodies.

Author information

  • 1Centre d'Immunologie Pierre Fabre (CIPF), 5 Avenue NapolĂ©on III, F74160, Saint-Julien-en-Genevois, France. alain.beck@pierre-fabre.com

Abstract

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain insights into the successful strategies used by pharmaceutical companies so far to bring innovative drugs to the market. Many challenges will have to be faced in the next decade to bring more efficient and affordable antibody-based drugs to the clinic. Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.

PMID:
20414207
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk